# OnCo record accuscan-mrd (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/accuscan-mrd/>
  a schema:MedicalTest ;
  onco:kind "drug" ;
  schema:identifier "accuscan-mrd" ;
  schema:name "AccuScan"@en ;
  schema:alternateName "AccuraGen AccuScan"@en, "AccuScan" ;
  schema:description "A whole-genome blood test for leftover cancer from AccuraGen that corrects sequencing errors read by read, so it can add up thousands of a tumour's mutations."@en ;
  schema:url <https://onco.cc/drugs/accuscan-mrd/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://doi.org/10.1038/s44321-024-00115-0> ;
  onco:status "emerging" ;
  onco:tag "test", "mrd" ;
  onco:modality "Tumour-informed whole-genome ctDNA minimal residual disease test (single-read error correction)" ;
  onco:related <https://onco.cc/technologies/genome-wide-ctdna-mutation-integration/> ;
  onco:cancers <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/esophageal/>, <https://onco.cc/cancers/melanoma/> ;
  onco:technologies <https://onco.cc/technologies/mrd-testing/>, <https://onco.cc/technologies/liquid-biopsy/>, <https://onco.cc/technologies/wes-wgs/> ;
  onco:companies <https://onco.cc/companies/accuragen/> ;
  onco:terms <https://onco.cc/terms/mrd/>, <https://onco.cc/terms/ctdna/>, <https://onco.cc/terms/tumour-informed-assay/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-li-accuscan-embo-mol-med-2024/> .